A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
Public ClinicalTrials.gov record NCT06692764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants With Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-Density Lipoprotein Cholesterol
Study identification
- NCT ID
- NCT06692764
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Interventions
- AZD0780 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2024
- Primary completion
- Apr 17, 2025
- Completion
- May 1, 2025
- Last update posted
- Feb 17, 2026
2024 – 2025
United States locations
- U.S. sites
- 26
- U.S. states
- 10
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Inglewood | California | 90301 | — |
| Research Site | Northridge | California | 91325 | — |
| Research Site | Pomona | California | 91767 | — |
| Research Site | Boca Raton | Florida | 33434 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Miami | Florida | 33122 | — |
| Research Site | Miami | Florida | 33165 | — |
| Research Site | Miami | Florida | 33173 | — |
| Research Site | Miami | Florida | 33174 | — |
| Research Site | Ocala | Florida | 34474 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Chicago | Illinois | 60621 | — |
| Research Site | Potomac | Maryland | 20854 | — |
| Research Site | New Bedford | Massachusetts | 02740 | — |
| Research Site | New Windsor | New York | 12553 | — |
| Research Site | Beavercreek | Ohio | 45431 | — |
| Research Site | Horsham | Pennsylvania | 19044 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Austin | Texas | 78704 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | El Paso | Texas | 79905 | — |
| Research Site | Hurst | Texas | 76054 | — |
| Research Site | Mesquite | Texas | 75149 | — |
| Research Site | Paris | Texas | 75462 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06692764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06692764 live on ClinicalTrials.gov.